How do I compare Homopeptide and QYB on lead time to Ireland?

Details up front: Homopeptide · QYB · Ireland.

I would like the axes of comparison first and the recommendation second.

I have tried the first option and it works; the question is whether the second is better rather than merely different.

What is the actual trade-off, and does it matter at the scale I am working at?

Ratings on this site are ours alone and are deliberately not reconciled with anyone else's.

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

No supplier on this site pays for its position, and the storefront links are marked nofollow and sponsored.

Use a fixed documentation checklist rather than an impression.

A single member running three suppliers on one method is worth more than thirty members running one supplier each.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

One laboratory, one method, one submission. Otherwise it is not a comparison.

The short version: same compound, same laboratory, same method, ideally same week — otherwise you are comparing laboratories rather than suppliers.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Price per milligram of measured peptide, not per milligram of label claim.

edited 9 Jan 2026 by esben_lykke — added a caveat about sampling

The relevant point is that two competent laboratories disagree by half a per cent on identical material, which is larger than most of the differences people argue about.

Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

Name the laboratory and the dates or the comparison cannot be reproduced.